Ameloblastoma in Siriraj Hospital: A 14-Year Retrospective Analysis of Clinicopathological Characteristics Correlating to the WHO 2017 Classification

Q4 Medicine
{"title":"Ameloblastoma in Siriraj Hospital: A 14-Year Retrospective Analysis of Clinicopathological Characteristics Correlating to the WHO 2017 Classification","authors":"","doi":"10.35755/jmedassocthai.2023.08.13817","DOIUrl":null,"url":null,"abstract":"Background: Ameloblastoma is a benign, locally aggressive neoplasm eliciting frequent relapse and morbidity. Based on many updates, there is an introduction of the World Health Organization (WHO) 2017 Classification in which the terminology has been modified and re-categorized.\n\nObjective: To study natural courses, the clinicopathological characteristics, and rate of recurrence of ameloblastoma patients in Siriraj Hospital.\n\nMaterials and Methods: The H&E stained slides of 122 patients diagnosed with ameloblastoma between 2006 and 2019 at Siriraj Hospital were reviewed and re-classified according to the WHO 2017 Classification. The natural course of disease and the clinicopathological characteristics were analyzed. A descriptive statistical analysis was used to calculate the frequency and percentages of different variables.\n\nResults: There were 86.9% of the cases being conventional ameloblastomas, whilst the predominant histologic pattern being the follicular pattern. The treatment of choice is excision. Recurrence of ameloblastoma is thought to be the consequence of several risk factors, clinicoradiological characteristics of the tumor, anatomical locations, treatments of choice, tumoral behavior, and tumor subtypes in particular. Thirty cases presented with recurrence, of which 83.3% were conventional ameloblastomas. Most of the cases were treated with radical treatment and have free surgical resection margins.\n\nConclusion: The clinicopathological characteristics and natural course of ameloblastoma patients in Siriraj Hospital corresponds to the WHO Classification. The present study demonstrated a high recurrence rate in patients treated with conservative surgery. Thus, the authors agree with the WHO 2017 Classification that radical surgery is recommended for patients with a history of recurrence and some specific subtypes of ameloblastomas.\n\nKeywords: Ameloblastoma; Mandible; Neoplasm; Odontogenic tumors; Oral pathology","PeriodicalId":17486,"journal":{"name":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35755/jmedassocthai.2023.08.13817","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Ameloblastoma is a benign, locally aggressive neoplasm eliciting frequent relapse and morbidity. Based on many updates, there is an introduction of the World Health Organization (WHO) 2017 Classification in which the terminology has been modified and re-categorized. Objective: To study natural courses, the clinicopathological characteristics, and rate of recurrence of ameloblastoma patients in Siriraj Hospital. Materials and Methods: The H&E stained slides of 122 patients diagnosed with ameloblastoma between 2006 and 2019 at Siriraj Hospital were reviewed and re-classified according to the WHO 2017 Classification. The natural course of disease and the clinicopathological characteristics were analyzed. A descriptive statistical analysis was used to calculate the frequency and percentages of different variables. Results: There were 86.9% of the cases being conventional ameloblastomas, whilst the predominant histologic pattern being the follicular pattern. The treatment of choice is excision. Recurrence of ameloblastoma is thought to be the consequence of several risk factors, clinicoradiological characteristics of the tumor, anatomical locations, treatments of choice, tumoral behavior, and tumor subtypes in particular. Thirty cases presented with recurrence, of which 83.3% were conventional ameloblastomas. Most of the cases were treated with radical treatment and have free surgical resection margins. Conclusion: The clinicopathological characteristics and natural course of ameloblastoma patients in Siriraj Hospital corresponds to the WHO Classification. The present study demonstrated a high recurrence rate in patients treated with conservative surgery. Thus, the authors agree with the WHO 2017 Classification that radical surgery is recommended for patients with a history of recurrence and some specific subtypes of ameloblastomas. Keywords: Ameloblastoma; Mandible; Neoplasm; Odontogenic tumors; Oral pathology
Siriraj医院成釉细胞瘤:与WHO 2017分类相关的14年临床病理特征回顾性分析
背景:成釉细胞瘤是一种良性的局部侵袭性肿瘤,易复发和发病。在多次更新的基础上,引入了世界卫生组织(世卫组织)2017年分类,其中对术语进行了修改和重新分类。目的:探讨诗丽拉医院成釉细胞瘤患者的自然病程、临床病理特点及复发率。材料与方法:对2006年至2019年在Siriraj医院诊断为成釉细胞瘤的122例患者的H&E染色玻片进行回顾,并根据世卫组织2017年分类进行重新分类。分析其自然病程及临床病理特征。使用描述性统计分析来计算不同变量的频率和百分比。结果:86.9%的病例为常规成釉细胞瘤,以滤泡型为主。治疗的选择是切除。成釉细胞瘤的复发被认为是几种危险因素的结果,包括肿瘤的临床放射学特征、解剖位置、治疗选择、肿瘤行为和肿瘤亚型。30例复发,其中83.3%为常规成釉细胞瘤。多数病例均行根治性治疗,并行游离切缘手术。结论:Siriraj医院成釉细胞瘤患者的临床病理特征和自然病程符合WHO分类。目前的研究表明,保守手术治疗的患者复发率很高。因此,作者同意世卫组织2017年的分类,建议对有复发史和某些特定亚型成釉细胞瘤的患者进行根治性手术。关键词:造釉细胞瘤;下颌骨;肿瘤;牙原性的肿瘤;口腔病理学
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信